Introduction {#s0001}
============

Systemic lupus erythematosus (SLE) is an archetype of systemic autoimmune disease with no available cure and at only remission can be achieved by medication.[@cit0001] Adrenocortical hormone or immunosuppression is still the main treatment regimen for SLE. However, long-term use of glucocorticoids and immunosuppressants in SLE patients can lead to immune impairment, resulting in is a high risk of opportunistic infections, such as opportunistic fungal infections, which are often severe and can cause patient death if not treated promptly.

The *Penicillium* genus is common and diverse in nature, and contains approximately 350 species, which may cause opportunistic infection in humans.[@cit0002] Notably, these species are often contaminants in clinical specimens, and isolated from the lungs as a result of colonization after inhalation of conidia. Here, we reported a case of severe pneumonia in an SLE patient from whom *Penicillium janthinellum* was isolated from sputum and bronchoalveolar lavage (BAL) samples. The patient died 10 days after diagnosis. We believe that *P. janthinellum* was the cause of the severe bilateral pneumonia with consolidation in this patient according to results of chest computed tomography (CT), the aspergillus galactomannan (GM) test and culture.

Case Presentation {#s0002}
=================

The patient was a 64-year-old female. She was admitted because of fever and cough for 1 week. She had suffered from hypertension for more than ten years. She had been diagnosed with SLE 10 months previously because after developing a rash, which was mainly distributed in the skin, neck and both upper limbs. Meanwhile, laboratory tests showed positive results for anti-DS-DNA and anti-SSA antibody spectra. She was further diagnosed with membranous lupus nephritis based on pathological findings of renal puncture 7 months ago prior to admission. Her medications included methylprednisolone 24 mg once daily, cyclosporine 50 mg twice daily and hydroxychloroquine 0.2g twice daily, amlodipine 5mg once daily, febuxostat 40 mg once daily combined with a sodium bicarbonate tablet 0.5g three times a day, warfarin tablets 2.5mg once daily, torasemide 10mg once daily, potassium chloride 0.5 g once-daily. After treatment at a local hospital, the rash subsided. However, the urine protein of the patient remained positive, with an elevated erythrocyte sedimentation rate and hypoproteinaemia, and the patient therefore remained on immunosuppressive therapy.

A physical examination revealed a weak state. Her temperature was 36.4°C on admission (maximum temperature 38.5°C), her heart rate was 85 beats/min, her respiratory rate was 18/min, and her blood pressure was 140/76 mmHg. No obvious dry or wet rales were noted in either lung by auscultation. Laboratory data showed a white blood cell count of 6360/mm^3^, with 92.6% polymorphonuclear cells, 4.9% lymphocytes, and 2.1% monocytes. Platelets (34\*10^9^/L) were significantly decreased. Serum complement C3 (0.69g/L) and serum albumin (23.5 g/L) were reduced. Ur Prot/UrCreat (6.51g/g) was significantly elevated. The result of anti-DS-DNA result was negative, but anti-SSA antibody spectra were weakly positive (1:32). CD3+ (348\*10^6^/L), CD4+ (168\*10^6^/L) and CD8+ (180\*10^6^/L) lymphocyte subsets had a significantly decreased. In addition, the patient tested negative for human immunodeficiency virus (HIV).

The chest CT showed pneumonia in both lungs ([Figure 1A](#f0001){ref-type="fig"}). The patient was diagnosed with pneumonia, and received treatment with sulfamethoxazole and cefuroxime. The patient's body temperature fluctuated between 36°C and 38°C during hospitalization, and her pulmonary infection did not improve. It is necessary to exclude pulmonary tuberculosis and *pneumocystis jiroveci pneumonia* (PJP). Sputum for gram stain, culture and acid-fast smear was obtained. Culture of the sputum generated abundant normal oropharyngeal flora and *Candida tropicalis*. In addition, blood cultures were negative.Figure 1The chest CT showed nodules and patches in the upper lobe of the left lung on admission (**A**); enlarged lesions in the upper lobe of both lungs and bilateral pleural effusions were observed on the 13th day after admission (**B**); bilateral infiltrates, interstitial infiltrates, alveolar infiltrates and bilateral pleural effusion were observed on the 20th day after admission (**C**).

The patient remained febrile, with a temperature as high as 39.1°C. A repeat chest CT also showed further infection in both lungs compared with that at admission ([Figure 1B](#f0001){ref-type="fig"}). A bronchoscopy with BAL was performed. Purulent secretions were observed and a sample was taken from the left upper lung. A large amount of mould was also isolated in large amounts from the BAL fluid. BAL fluid stained with Gram, fluorescence and hexamine silver stains showed the presence of somewhat dichotomously branching septate fungal hyphae ([Figure 2A](#f0002){ref-type="fig"}--[C](#f0002){ref-type="fig"}). The GM results in the BAL and serum were 1.85 μg/L and 0.89 μg/L, respectively. According to the latest guidelines for invasive fungi, the GM results indicated the presence of fungal infection.[@cit0003] Sulfamethoxazole and cefuroxime were discontinued and a new regimen of micafungin (150mg/d) and ganciclovir was initiated. The patient began to defervesce but the repeat chest CT also showed further infection in both lungs ([Figure 1C](#f0001){ref-type="fig"}). The patient died 10 days later. No autopsy was performed.Figure 2Yeast forms of *Penicillium janthinellum* in BAL washings stained with fluorescence (**A**, Original magnification X 400), Gram stains (**B**, Original magnification X 1000), hexamine silver (**C**, Original magnification X 400) and fungal morphology stained with medan lactate (**D**, Original magnification X 400). Colony morphology in the obverse side was cultured in 28 °C PDA medium for 5 days (**E**) and Colony morphology in the reverse side (**F**) was cultured in 28 °C PDA medium for 14 days.

The purulent secretions were cultured on Sabouraud dextrose agar (SDA) (Emmon's modification) and on SDA with chloramphenicol at 28°C.The fungus grew at 28°C on SDA and on SDA with chloramphenicol. No growth was observed on Mycosel agar. Fungal morphology stained with Medan lactate showed a branching mycelium. Conidial terrier grew from the side ends of hyphae and formed a short broom at the top. The stem of the bottle was in the shape of a bottle. The conidia were spherical or elliptic (3--6 μm in diameter) ([Figure 2D](#f0002){ref-type="fig"}). The organism had white-coloured villiform and produced a slight yellow pigment on the reverse side, showing that had the most pronounced growth at 5 days on potato dextrose agar ([Figure 2E](#f0002){ref-type="fig"}). Notably, the organism developed a purple pigment on the reverse side after 14 days of growth on potato dextrose agar ([Figure 2F](#f0002){ref-type="fig"}). Attempts to identify the fungus were unsuccessful by morphology and the MALDI-TOF-MS system. The isolate was identified by sequencing using primers (ITS1: 5ʹ-TCCGTAGGTGAACCTGCGG-3ʹ; ITS4: 5ʹ-TCCTCCGCTTATTGATATGC-3ʹ). The mould was later identified as *P. janthinellum* by its DNA sequence. Antibiotic susceptibility testing was performed using a microdilution technique (CLSI M38-A2) (Clinical and Laboratory Standards Institute, 2008).[@cit0004] Antibiotic susceptibility profiles showed that this strain had higher minimum inhibitory concentrations (MIC) values in response to many antifungal drugs ([Table 1](#t0001){ref-type="table"}).Table 1Fungal SusceptibilityAntifungal AgentsMICS (μg/mL)Caspofungin\>8Micafungin\>8Anidulafungin\>8Voriconazole\>1Posaconazole\>0.125ʹflucytosine\>8Itraconazole\>0.25Fluconazole\>256Amphotericin B\>4

Discussion and Conclusions {#s0003}
==========================

The genus *Penicillium* includes approximately 350 species, including *Paecilomyces, Fusarium, Scopulariopsis, Acremonium* and *Beauveria*. Currently, these species play significant and varied roles in food manufacturing.[2](#cit0002),[@cit0005] *P. janthinellum* is a very common organism, which that mainly exists in a variety of habitats, such as soil, vegetation, air and food products. It has the characteristics of fast growth and reproduction and strong adaptability, and can grow and reproduce in the absence of oxygen and a certain concentration of carbon dioxide. In addition, this organism can produce a variety of toxins, such as verrucosporin, citrinin, and janthitrems curnlic acid.[@cit0006] Because *Penicillium* species are common in nature, these species are usually considered contaminants when they were isolated from clinical specimens, but they have also been demonstrated to cause human disease.[@cit0007] Systemic infections caused by *Penicillium marneffei* have been reported in immunocompromised patients.[@cit0008],[@cit0009] These mycelial fungi can cause various nosocomial infections in immunocompromised hosts. *P. janthinellum* had been shown to cause a neurologic disease in sheep and cattle (known as rye grass staggers) as a result of its ability to produce tremorgenic toxins.[@cit0006],[@cit0010] In addition, *P janthinellum* can cause soft drink food poisoning.[@cit0007] To date, only one study has reported an infection (pneumonia) caused by *P. janthinellum* in an AIDS patient.[@cit0011] To the best of our knowledge, this report is the second to demonstrate that *P. janthinellum* causes infection and is the first to present an infection (pneumonia) caused by *P. janthinellum* in an SLE patient. Immunocompromised patients are at a high risk for developing severe life-threatening illnesses caused by opportunistic fungal pathogens. This species of *Penicillium* was detected from the patient's sputum and bronchoalveolar samples, and this is the second report of pneumonia caused by this organism.

BAL is an effective method to collect bronchial and alveolar secretions from patients with pneumonia to facilitate diagnosis and treatment. In our case, *P. janthinellum* was isolated from sputum and bronchoalveolar washings samples, which we therefore believe may be the cause of the severe bilateral pneumonia. Although she was not neutropenic during her illness, the patient was severely immunodeficient. Notably, the infection was neglected by the clinics and laboratories due to a lack of understanding of *P. janthinellum*, which may be an important cause of the patients' death. Azole drugs may be effective for treating this fungus according to the result of the drug sensitivity analysis. In addition, we are aware of one limitation of this study. Because no autopsy was performed, the nature of the infection was not confirmed histopathologically or by tissue culture.

Our case is notable for several reasons. First, this report is the first to present a *P. janthinellum* caused infection (pneumonia) in an SLE patient. Second, this case further highlights the need for clinicians to be cognizant of the immunosuppressors capable of inciting disease in patients with compromised immunity. Third, clinical and laboratory personnel should be aware that the *Penicillium* genus also contains pathogenic bacteria that cannot simply be treated as contaminants, especially in immunosuppressed patients. Fungal identification and antifungal drug sensitivity testing should also be carried out as soon as possible to provide direction for clinical drug selection.
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SLE, systemic lupus erythematosus; BAL, bronchoalveolar; CT, computed tomography; PJP, *Pneumocystis jiroveci* pneumonia; GM, Aspergillus galactomannan; SDA, Sabouraud dextrose agar; MIC, minimum inhibitory concentration.
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